Respiratory Tract Diseases
The research site concentrates on clinical studies of mild to moderate asthma, seeking to advance therapeutic options for this common respiratory condition.
- Evaluation of therapeutic equivalence between inhaler formulations
- Measurement of lung function using forced expiratory volume in 1 second (FEV1) endpoints
- Assessment of safety and efficacy in adult asthma patients
Ongoing work at Michał Bogacki – DOBROSTAN aims to improve treatment options for people with asthma by confirming that new inhaler technologies perform as well as established products.
